Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association Provide Guidance on Pulmonary Hypertension Related to Interstitial Lung Disease
The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD). The PH-ILD position statement, featuring a version for…
Timely Diagnosis And Early Intervention Of Alzheimer’s Is The Need Of The Hour: Doctors
Alzheimer’s disease (AD) is the most common factor behind dementia, a general term for memory loss and other cognitive abilities that tend to interfere with one’s daily routine. It can impact one’s physical, mental, and emotional well-being. Early diagnosis and…
AstraZeneca partners with Alveofit to scale up the diagnosis and treatment of lung diseases in India.
Under the aegis of its A.Catalyst network, AstraZeneca India announced its partnership with Alveofit, a SaaS-IoT enabled respiratory healthcare platform, to offer IoT enabled handheld spirometers at hospitals across the country. This partnership aims to embed latest technological advancements in…